ReviewInternational ophthalmology2026
Artificial intelligence in cataract management: current status and future perspectives.
Review in International ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo summarize recent advances in artificial intelligence (AI) applications across the entire cataract management pathway and to discuss current challenges and future directions.
methodsWe conducted a narrative mini review of studies published since 2021 on AI applications in cataract diagnosis and screening, intraocular lens (IOL) power calculation, intraoperative guidance, and postoperative management, with emphasis on deep learning and emerging technologies.
resultsAI models have achieved expert-level performance in automated cataract detection and grading from slit-lamp images, with pooled AUC values approaching 0.99 in meta-analyses. AI-based IOL power calculation formulas have shown superior accuracy compared with traditional formulas, especially in challenging cases such as highly myopic eyes. Intraoperatively, AI systems can recognize surgical phases and track instruments with high accuracy, supporting surgical training and quality assessment. Postoperatively, multimodal AI models integrating imaging and clinical data have improved the prediction of visual outcomes and complications. Emerging technologies, including large language models, portable smartphone-based screening devices, and multimodal prediction models, represent promising new directions, although challenges related to data generalizability, algorithm interpretability, and clinical translation remain to be addressed.
conclusionAI has the potential to significantly improve the efficiency, accuracy, and accessibility of cataract care, but should serve as an assistive tool rather than a replacement for clinical judgment.
Indexed as
Identifiers
42814183What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.